EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE : revenue, balance sheet and financial ratios

EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE is a French company founded 4 years ago, specialized in the sector Analyses, essais et inspections techniques. Based in NANTES (44300), this company of category GE shows in 2024 a revenue of 704 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE (SIREN 907791321)
Kennzahl 2024 2023 2022 2021
Umsatz 703 995 € 643 136 € 554 078 € N/C
Nettoergebnis 22 285 € -225 035 € -442 103 € -11 400 €
EBITDA 54 305 € -230 185 € -541 459 € -11 400 €
Nettomarge 3.2% -35.0% -79.8% N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE achieves revenue of 704 k€. Over the period 2022-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +12.7%. Vs 2023: +9%. After deducting consumption (0 €), gross margin stands at 704 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 54 k€, representing 7.7% of revenue. Positive scissor effect: EBITDA margin improves by +43.5 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 22 k€, i.e. 3.2% of revenue. This profit can be retained or distributed to shareholders.

Umsatz (2024) ?
Umsatz
Definition
Gesamtbetrag der Verkäufe von Waren und Dienstleistungen des Unternehmens.
Formel
Warenverkäufe + Verkaufte Produktion

703 995 €

Bruttomarge (2024) ?
Bruttomarge
Definition
Differenz zwischen Umsatz und Wareneinsatz.
Formel
Umsatz - Wareneinsatz

703 995 €

EBITDA (2024) ?
EBITDA (Betriebsergebnis vor Abschreibungen)
Definition
Ressource générée par l'activité courante, avant amortissements et charges financières.
Formel
Wertschöpfung - Personalkosten - Steuern
Interpretation
Positiv = rentable Tätigkeit

54 305 €

EBIT (2024) ?
EBIT (Betriebsergebnis)
Definition
Betriebsergebnis, einschließlich Abschreibungen und Rückstellungen.
Formel
EBITDA - Abschreibungen und Rückstellungen + Auflösungen

42 829 €

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

22 285 €

EBITDA-Marge (2024) ?
EBITDA-Marge
Definition
Misst die operative Rentabilität des Unternehmens.
Formel
(EBE / CA) x 100
Interpretation
> 10% : Gute Rentabilität
5-10% : Durchschnitt
< 5% : Faible

7.7%

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at -103%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -106%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 8.1 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 4.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

-103.398%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

-106.392%

Cashflow / Umsatz (2024) ?
Cashflow / Umsatz
Definition
Capacité d'autofinancement rapportée au chiffre d'affaires.
Formel
(CAF / CA) x 100
Interpretation
Je höher das Verhältnis, desto mehr Liquidität generiert das Unternehmen

4.72%

Rückzahlungsfähigkeit (2024) ?
Rückzahlungsfähigkeit
Definition
Anzahl der Jahre zur Schuldenrückzahlung mit dem Cashflow.
Formel
Dettes financières / CAF
Interpretation
< 3 Jahre : Ausgezeichnet
3-5 Jahre : Angemessen
> 5 Jahre : Attention

8.129

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

8.9%

Entwicklung der Solvenzkennzahlen
EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE

Positionnement sectoriel

Debt ratio
-103.4 2024
2022
2023
2024
Q1: 0.0
Méd: 9.99
Q3: 48.5
Excellent

In 2024, the debt ratio of EUROFINS TOXICOLOGICAL AN... (-103.40) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-106.39% 2024
2022
2023
2024
Q1: 11.63%
Méd: 34.78%
Q3: 58.76%
Watch

In 2024, the financial autonomy of EUROFINS TOXICOLOGICAL AN... (-106.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
8.13 years 2024
2022
2023
2024
Q1: 0.0 years
Méd: 0.0 years
Q3: 0.87 years
Watch +51 pts über 3 Jahre

In 2024, the repayment capacity of EUROFINS TOXICOLOGICAL AN... (8.13) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 156.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 39.6x. Operating income very largely covers interest expenses: high safety margin.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

156.609

Zinsdeckung (2024) ?
Zinsdeckung
Definition
Fähigkeit, Zinsaufwendungen mit dem Betriebsergebnis zu decken.
Formel
EBIT / Zinsaufwendungen
Interpretation
> 3 : Komfortabel
1.5-3 : Acceptable
< 1.5 : Risiko

39.639

Entwicklung der Liquiditätskennzahlen
EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE

Positionnement sectoriel

Liquidity ratio
156.61 2024
2022
2023
2024
Q1: 133.14
Méd: 205.95
Q3: 337.03
Average +9 pts über 3 Jahre

In 2024, the liquidity ratio of EUROFINS TOXICOLOGICAL AN... (156.61) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
39.64x 2024
2022
2023
2024
Q1: 0.0x
Méd: 0.02x
Q3: 2.48x
Excellent +50 pts über 3 Jahre

In 2024, the interest coverage of EUROFINS TOXICOLOGICAL AN... (39.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 80 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 60 days. The company must finance 20 days of gap between collections and payments. Overall, WCR represents 25 days of revenue, i.e. 49 k€ to permanently finance.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

48 752 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

80 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

60 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Working Capital in Umsatztagen (2024) ?
Working Capital in Umsatztagen
Definition
Drückt den Betriebskapitalbedarf in Umsatztagen aus.
Formel
(BFR exploitation / CA) x 360
Interpretation
Je weniger Tage, desto besser das Working Capital Management

25 j

Entwicklung des Working Capital und der Zahlungsfristen
EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE

Positionnement de EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE dans son secteur

Vergleich mit der Branche Analyses, essais et inspections techniques

Bewertungsschätzung

Indicative estimate only : the number of comparable transactions in this sector is limited (41 transactions). This range of 37 067€ to 304 315€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
37k€ 179k€ 304k€
179 817 € Range: 37 067€ - 304 315€
NAF 5 année 2024

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 41 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Analyses, essais et inspections techniques)

Compare EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE with other companies in the same sector:

Frequently asked questions about EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE

What is the revenue of EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE ?

The revenue of EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE in 2024 is 704 k€.

Is EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE profitable?

Yes, EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE generated a net profit of 22 k€ in 2024.

Where is the headquarters of EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE ?

The headquarters of EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE is located in NANTES (44300), in the department Loire-Atlantique.

Where to find the tax return of EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE ?

The tax return of EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE operate?

EUROFINS TOXICOLOGICAL AND REGULATORY EXPERTISE C&PC FRANCE operates in the sector Analyses, essais et inspections techniques (NAF code 71.20B). See the 'Sector positioning' section above to compare the company with its competitors.